Search research articles
Contact Us
Filters
Showing results (171-180 of 189) with videos related to
Page
of 19
Sort By:
Chemical Biology & Drug Design
|
January 16, 2015
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors
Stefano Sabatini, Giuseppe Manfroni, Maria Letizia Barreca, et al.
European Journal of Medicinal Chemistry
|
August 25, 2019
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation
Andrea Astolfi, Mark Kudolo, Jose Brea, et al.
Journal of Medicinal Chemistry
|
March 24, 2025
Uncovering α-Selectivity for Liver X Receptor Agonists for Lipotoxic Cancer Therapies
Júlia Galvez B Pedreira, Pascal Woelffing, Moritz Schwarz, et al.
Nature Medicine
|
November 9, 2019
Preventing dysbiosis of the neonatal mouse intestinal microbiome protects against late-onset sepsis
Jeffrey R Singer, Emily G Blosser, Carlene L Zindl, et al.
ACS Medicinal Chemistry Letters
|
December 15, 2022
Structural Basis for Inhibition of Mutant EGFR with Lazertinib (YH25448)
David E Heppner, Florian Wittlinger, Tyler S Beyett, et al.
Nature Communications
|
February 12, 2024
The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma
Stephan Spahn, Fabian Kleinhenz, Ekaterina Shevchenko, et al.
Immunity
|
April 16, 2020
Insulin-Like Growth Factors Are Key Regulators of T Helper 17 Regulatory T Cell Balance in Autoimmunity
Daniel DiToro, Stacey N Harbour, Jennifer K Bando, et al.
Human Molecular Genetics
|
November 14, 2018
Genetic influences on susceptibility to rheumatoid arthritis in African-Americans
Vincent A Laufer, Hemant K Tiwari, Richard J Reynolds, et al.
ACS Pharmacology & Translational Science
|
April 18, 2024
Correction to "Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity"
Philipp Flury, Julian Breidenbach, Nadine Krüger, et al.
ACS Pharmacology & Translational Science
|
February 15, 2024
Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity
Philipp Flury, Julian Breidenbach, Nadine Krüger, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 189) with videos related to
Sort By:
Page
of 19
Chemical Biology & Drug Design
|
January 16, 2015
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors
Stefano Sabatini, Giuseppe Manfroni, Maria Letizia Barreca, et al.
European Journal of Medicinal Chemistry
|
August 25, 2019
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation
Andrea Astolfi, Mark Kudolo, Jose Brea, et al.
Journal of Medicinal Chemistry
|
March 24, 2025
Uncovering α-Selectivity for Liver X Receptor Agonists for Lipotoxic Cancer Therapies
Júlia Galvez B Pedreira, Pascal Woelffing, Moritz Schwarz, et al.
Nature Medicine
|
November 9, 2019
Preventing dysbiosis of the neonatal mouse intestinal microbiome protects against late-onset sepsis
Jeffrey R Singer, Emily G Blosser, Carlene L Zindl, et al.
ACS Medicinal Chemistry Letters
|
December 15, 2022
Structural Basis for Inhibition of Mutant EGFR with Lazertinib (YH25448)
David E Heppner, Florian Wittlinger, Tyler S Beyett, et al.
Nature Communications
|
February 12, 2024
The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma
Stephan Spahn, Fabian Kleinhenz, Ekaterina Shevchenko, et al.
Immunity
|
April 16, 2020
Insulin-Like Growth Factors Are Key Regulators of T Helper 17 Regulatory T Cell Balance in Autoimmunity
Daniel DiToro, Stacey N Harbour, Jennifer K Bando, et al.
Human Molecular Genetics
|
November 14, 2018
Genetic influences on susceptibility to rheumatoid arthritis in African-Americans
Vincent A Laufer, Hemant K Tiwari, Richard J Reynolds, et al.
ACS Pharmacology & Translational Science
|
April 18, 2024
Correction to "Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity"
Philipp Flury, Julian Breidenbach, Nadine Krüger, et al.
ACS Pharmacology & Translational Science
|
February 15, 2024
Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity
Philipp Flury, Julian Breidenbach, Nadine Krüger, et al.
Page
of 19